FDA concedes SOBI’s IND application for SOBI003 along with Fast Track Status for treating MPS IIIA Read more
Evofem Biosciences enrolls first patient in Phase 2b/3 Clinical Trial assessing Amphora’s ability to foil UCG in women Read more
ProMIS Neurosciences claimed further results of previously claimed Preclinical program for Alzheimer’s Disease Read more
CHMP of EMA conveyed negative trend vote of Puma’s MA for neratinib for treating HER2-positive Breast Cancer Read more